106 related articles for article (PubMed ID: 7965775)
41. Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.
Ben Mosbah I; Mouchel Y; Pajaud J; Ribault C; Lucas C; Laurent A; Boudjema K; Morel F; Corlu A; Compagnon P
PLoS One; 2012; 7(11):e50235. PubMed ID: 23226251
[TBL] [Abstract][Full Text] [Related]
42. L-cysteine augments the vasorelaxation induced by sodium nitrite and SIN-1 but not that due to acetylcholine.
Arvola P; Pörsti I; Vuorinen P; Huhtala H; Metsä-Ketelä T; Vapaatalo H
Eur J Pharmacol; 1992 Apr; 214(2-3):289-92. PubMed ID: 1325360
[TBL] [Abstract][Full Text] [Related]
43. A novel neurogenic vasodilator mechanism in bovine mesenteric artery.
Axelsson KL; Ljusegren ME; Ahlner J; Grundström N
Circ Res; 1989 Oct; 65(4):903-8. PubMed ID: 2791226
[TBL] [Abstract][Full Text] [Related]
44. General toxicology of MnDPDP.
Larsen LE; Grant D
Acta Radiol; 1997 Jul; 38(4 Pt 2):770-9. PubMed ID: 9245973
[TBL] [Abstract][Full Text] [Related]
45. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?
Brurok H; Ardenkjaer-Larsen JH; Hansson G; Skarra S; Berg K; Karlsson JO; Laursen I; Jynge P
Biochem Biophys Res Commun; 1999 Jan; 254(3):768-72. PubMed ID: 9920816
[TBL] [Abstract][Full Text] [Related]
46. Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Blazak WF; Brown GL; Gray TJ; Treinen KA; Denny KH
Fundam Appl Toxicol; 1996 Sep; 33(1):11-5. PubMed ID: 8812204
[TBL] [Abstract][Full Text] [Related]
47. Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP.
Yang J; Wu EX
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():4775-8. PubMed ID: 19964849
[TBL] [Abstract][Full Text] [Related]
48. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography.
Toft KG; Friisk GA; Skotland T
J Pharm Biomed Anal; 1997 Apr; 15(7):973-81. PubMed ID: 9160264
[TBL] [Abstract][Full Text] [Related]
49. Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase.
Toft KG; Myrset AH; Skotland T
J Pharm Biomed Anal; 2001 Jun; 25(3-4):613-8. PubMed ID: 11377042
[TBL] [Abstract][Full Text] [Related]
50. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
[TBL] [Abstract][Full Text] [Related]
51. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
Suto Y; Weinreb JC; Rofski NM
J Comput Assist Tomogr; 1996; 20(4):647-9. PubMed ID: 8708073
[TBL] [Abstract][Full Text] [Related]
52. Dynamic evaluation of the hepatic uptake and clearance of manganese-based MRI contrast agents: a 31P NMR study on the isolated and perfused rat liver.
Colet JM; Vander Elst L; Muller RN
J Magn Reson Imaging; 1998; 8(3):663-9. PubMed ID: 9626883
[TBL] [Abstract][Full Text] [Related]
53. Prevention of 7β-hydroxycholesterol-induced cell death by mangafodipir is mediated through lysosomal and mitochondrial pathways.
Laskar A; Miah S; Andersson RG; Li W
Eur J Pharmacol; 2010 Aug; 640(1-3):124-8. PubMed ID: 20452343
[TBL] [Abstract][Full Text] [Related]
54. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts.
Brurok H; Skoglund T; Berg K; Skarra S; Karlsson JO; Jynge P
NMR Biomed; 1999 Oct; 12(6):364-72. PubMed ID: 10516618
[TBL] [Abstract][Full Text] [Related]
55. Physicochemical characterisation of mangafodipir trisodium.
Tirkkonen B; Aukrust A; Couture E; Grace D; Haile Y; Holm KM; Hope H; Larsen A; Lunde HS; Sjøgren CE
Acta Radiol; 1997 Jul; 38(4 Pt 2):780-9. PubMed ID: 9245974
[TBL] [Abstract][Full Text] [Related]
56. Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction.
Grant D; Toft KG; Martinsen I; Atzpodien E
Acta Radiol; 1997 Jul; 38(4 Pt 2):732-9. PubMed ID: 9245969
[TBL] [Abstract][Full Text] [Related]
57. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.
Hustvedt SO; Grant D; Southon TE; Zech K
Acta Radiol; 1997 Jul; 38(4 Pt 2):690-9. PubMed ID: 9245964
[TBL] [Abstract][Full Text] [Related]
58. Fodipir and its dephosphorylated derivative dipyridoxyl ethyldiamine are involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death.
Laskar A; Andersson RG; Li W
Pharmacology; 2013; 92(3-4):182-6. PubMed ID: 24080534
[TBL] [Abstract][Full Text] [Related]
59. Detection of acute myocardial ischemia using first-pass dynamics of MnDPDP on inversion recovery echoplanar imaging.
Wyttenbach R; Saeed M; Wendland MF; Geschwind JF; Bremerich J; Arheden H; Higgins CB
J Magn Reson Imaging; 1999 Feb; 9(2):209-14. PubMed ID: 10077015
[TBL] [Abstract][Full Text] [Related]
60. A new opportunity for MEMRI.
Cloyd R; Vandsburger M; Abisambra JF
Aging (Albany NY); 2017 Aug; 9(8):1855-1856. PubMed ID: 28854148
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
